TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,836 | -65.2% | 40,411 | +3.5% | 0.00% | -62.5% |
| Q2 2023 | $970,126 | +61.2% | 39,055 | -2.4% | 0.01% | +60.0% |
| Q1 2023 | $601,705 | +30.6% | 40,007 | +2.7% | 0.01% | +25.0% |
| Q4 2022 | $460,696 | +108.5% | 38,943 | +4.4% | 0.00% | +100.0% |
| Q3 2022 | $221,000 | +41.7% | 37,288 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $156,000 | -50.0% | 36,801 | +12.0% | 0.00% | -33.3% |
| Q1 2022 | $312,000 | -49.8% | 32,844 | +0.5% | 0.00% | -40.0% |
| Q4 2021 | $621,000 | -43.0% | 32,676 | -0.2% | 0.01% | -44.4% |
| Q3 2021 | $1,090,000 | -11.7% | 32,755 | +2.9% | 0.01% | -10.0% |
| Q2 2021 | $1,235,000 | -16.3% | 31,842 | +4.0% | 0.01% | -23.1% |
| Q1 2021 | $1,476,000 | -3.5% | 30,622 | +4.2% | 0.01% | -7.1% |
| Q4 2020 | $1,529,000 | +91.6% | 29,383 | -1.5% | 0.01% | +75.0% |
| Q3 2020 | $798,000 | +130.6% | 29,816 | +67.8% | 0.01% | +60.0% |
| Q2 2020 | $346,000 | +67.1% | 17,774 | -15.5% | 0.01% | +25.0% |
| Q1 2020 | $207,000 | – | 21,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |